Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Brenner, Barry M., Cooper, Mark E., de Zeeuw, Dick, Keane, William F., Mitch, William E., Parving, Hans-Henrik, Remuzzi, Giuseppe, Snapinn, Steven M., Zhang, Zhonxin, Shahinfar, Shahnaz·2001·New England Journal of Medicine
DOI 10.1056/nejmoa011161

Cited by (7,495)

Items 6,901–7,000 of 7,495

  1. The Boomers Come of Age
    Ashley Klaczak Mudra · 2020 · Physician Assistant Clinics
  2. The effect of Renin Angiotensin System Blockers versus Calcium Channel Blockers on Progression towards Hypertensive Chronic Kidney Disease: A comprehensive systematic review based on Randomized Controlled Trials
    Ameena Rafeeque, M Fasihul Alam · 2020 · University of the Future: Re-Imagining Research and Higher Education
  3. Blutdruckbehandlung bei Diabetes mellitus
    Christiane Brockes · 2002 · pharma-kritik
  4. Kidney Disease in Hypertension
    Suneel Udani, Ivana Lazich, George L. Bakris · 2012 · Elsevier eBooks
  5. Proteinuria
    Chris Isles · 2007 · Elsevier eBooks
  6. Meta-Analyses of Hypertension Trials
    Hisatomi Arima, Fiona Turnbull, Bruce Charles Neal · 2012 · Elsevier eBooks
  7. Angiotensin Receptor Blockers
    W.J. Elliott, Henry Richard Black · 2012 · Elsevier eBooks
  8. Néphropathie diabétique
    2014 · Elsevier eBooks
  9. Chapter 35 – Treatment of Hypertension in Patients with Renal Disease
    Nitin Khosla, G. Bakris · 2007 · Cardiovascular Therapeutics
  10. Thérapeutique des désordres associés
    2010 · Elsevier eBooks
  11. Néphropathie diabétique
    2010 · Elsevier eBooks
  12. Diuretics
    John Francis Setaro, Marvin Moser · 2007 · Elsevier eBooks
  13. Hypertension
    David G. Warnock, Stephen C. Textor · 2004 · American Journal of Kidney Diseases
  14. Thérapeutique des désordres associés
    2014 · Elsevier eBooks
  15. Renovaskuläre Effekte von SGLT-2-Inhibitoren
    Bernd Hohenstein, Christian Hugo · 2020 · Diabetes aktuell
  16. Effektivnost' primeneniya kandesartana pri gipertonicheskoy boleznii nefrogennoy arterial'noy gipertonii
    Чихладзе Новелла Михайловна, Сивакова Ольга Анатольевна, E V Blinova · 2008 · Systemic Hypertension
  17. Sartans in cardiological practice: new possibilities in therapy of cardiovascular diseases
    Olga G. Smolenskaya · 2009 · Systemic Hypertension
  18. Blokatory retseptorov k angiotenzinu II v lechenii diabeticheskoy nefropatii s pozitsiy dokazatel'noy meditsiny
    Marina Vladimirovna Shestakova · 2006 · Systemic Hypertension
  19. Sakharnyy diabet i arterial'naya gipertoniya: kakovy preparaty pervogo ryada vybora?
    Marina Vladimirovna Shestakova · 2005 · Systemic Hypertension
  20. DIABETES & HYPERTENSION: THE SIAMESE TWINS
    Trinath Kumar Mishra, Biswajit Das, Nirmal Kumar Mohanty · 2014 · Journal of Evidence Based Medicine and Healthcare
  21. ERKRANKUNGEN DER NIERE
    Norma Jung, W.-J. Mayet, Peter Rene Mertens, J. Meyer (federführend), O.-A. Müller, M. Pfeifer, Peter Dieter Schellinger, N. Weiss, Clemens‐Martin Wendtner · 2020 · Elsevier eBooks
  22. Dinamika skorosti klubochkovoy fil'tratsii - samostoyatel'naya mishen' antigipertenzivnoy terapii: vozmozhnosti eprosartana
    Victor V. Fomin · 2008 · Systemic Hypertension
  23. Relationship between URAT1 Gene Polymorphism and Uric Acid-Lowering Effect of Losartan in Hypertensive Patients with Hyperuricemia
    Ying Wang, Yingchao Fan, Liting Wu · 2020 · Indian Journal of Pharmaceutical Sciences
  24. Nephrology Consultative Approach and Risk Stratification Prior to Revascularization in Chronic Kidney Disease
    Roy O. Mathew, Valerian L.C. Fernandes, Sripal Bangalore · 2020 · Springer eBooks
  25. Relationship between postprandial hyperglycaemia and Progression of Diabetic Nephropathy
    Ali S.Abdul-Razzaq Al-hilli, H. Abdulkareem · 2017 · AL-QADISIYAH MEDICAL JOURNAL
  26. Changes over the past 33 Years at Urayasu Hospital
    Hisaki Rinno · 2020 · Juntendō Igaku/Juntendo igaku
  27. Das geht an die Nieren!
    Christiane Drechsler, Andreas Schneider, Kay-Renke Schmidt, Christoph Wanner · 2014 · MMW - Fortschritte der Medizin
  28. Das geht an die Nieren!: Schlechte Blutzuckereinstellung bei Diabetes mellitus
    Christiane Drechsler, Andreas Schneider, Kay-Renke Schmidt, Christoph Wanner · 2014 · MMW - Fortschritte der Medizin
  29. Inhibiteurs de SGLT2 et maladies rénales : les résultats impressionnants de DAPA-CKD
    S. Halimi · 2020 · Médecine des Maladies Métaboliques
  30. Proceedings From a Canadian Nephrology Forum: Nephrology Is Back
    Adeera Levin, Daniel Sapir, Andrew Steele · 2020 · Canadian Journal of Kidney Health and Disease
  31. Perspectives of chronic renal failure
    Kiyoshi Kurokawa, Masaomi Nangaku, Reiko Inagi · 2002 · Nephrology
  32. Initial Recognition and Prophecy of Diabetic Nephropathy in Type I Diabetes
    Wijdan Akram, Ficms, MBChB · 2012 · AL-Kindy College Medical Journal
  33. Chez les sujets avec insuffisance rénale chronique modérée et macroalbuminurie, diabétiques ou non, est-ce que la dapagliflozine amène un bénéfice rénal et cardiovasculaire comparativement au placébo ?
    Luc Lanthier, Mélanie Masse, M.-É. Plourde, Michel Cauchon · 2020 · La Revue de Médecine Interne
  34. Nondiabetic Renal Disease (NDRD) and Diabetic Kidney Disease (DKD)
    Koki Mise · 2020 · Springer eBooks
  35. Fixed combination of RAS blocker and calcium channel blocker: what to choose?
    О. В. Карпенко, С. А. Бондарчук · 2017 · Medicine of Ukraine
  36. Targeting Multiple Risk Factors to Reduce Complications of Type 2 Diabetes: Treatment Imperatives
    Pasquale J Palumbo · 2010 · Endocrine Practice
  37. Sartans` effects of chronic heart failure in a family doctor practice (literature review)
    Nadiia Volodymyrivna Demikhova · 2016 · Family Medicine
  38. Blood Pressure Management in Diabetic Kidney Disease
    Naoki Kashihara · 2020 · Springer eBooks
  39. Well Controlled Blood Pressure in Turkish Patients: How Many Drugs Are Required to Attain and Maintain the Blood Pressure Goal?
    Mustafa Temizel, Ugur Dilek Calap, Murtaza Çit · 2021 · International Journal of Clinical Medicine
  40. Tactics to prevent or slow progression of CKD in patients with diabetes
    Ahmad · 2021 · The Journal of Family Practice
  41. 糖尿病と心不全～病態・治療・予防～
    佐野 元昭 · 2020 · 心臓
  42. Making Sense of Chronic Kidney Disease in Primary Care Part 2 – Management
    2021 · The Singapore Family Physician
  43. Die Niere als Schrittmacher kardiovaskulärer Alterung
    Christoph Wanner, Jan Galle, Kai Lopau · 2021 · DMW - Deutsche Medizinische Wochenschrift
  44. Heart protection: a key target in the management of patients with diabetes
    Jean‐Jacques Mourad, Sylvain Le Jeune · 2009 · Journal of Hypertension
  45. MANAGEMENT OF HEART FAILURE
    Mohd Ismail Merican, Jeyamalar Rajadurai, D.S.P. Chew, Kah Lin, Robaayah Zambahari, Wan Azman, Aris Chandran, Yook Chin Chia · 2007
  46. The Effect of Empagliflozin on Kidney Injury Markers in Subjects with Type 2 Diabetes and Cardiovascular Disease: A Sub-analysis of the EMPA-HEART CardioLink-6 Trial
    Erika Opingari · 2019 · TSpace (University of Toronto)
  47. Diabetic Kidney Disease
    Ting Cai, Junwei Yang · 2019 · Springer eBooks
  48. revention of Loss of Renal Function Over Time in atients with Diabetic Nephropathy
    nthony Barnett · 2006
  49. RELACOES DA HIPERTENSAO ARTERIAL COM A TAXA DE EXCRECAO DE ALBUMINA NUMA CONSULTA HOSPITALAR DE HIPERTENSAO ARTERIAL E RISCO CARDIOVASCULAR RESUMO
    Jorge de Almeida, Berkeley Cotter, Relações da hipertensão, Nuno Sousa, António Celso Fontes · 2008
  50. Diabetic kidney disease and transplantation options
    Wan Shun Wong, Gerard A. McKay, Kathryn I Stevens · 2021 · Practical Diabetes
  51. Finerenon bei Patienten mit chronischer Nierenerkrankung und Diabetes mellitus Typ 2
    Christoph Wanner, Sirka Nitschmann · 2021 · Der Internist
  52. Reactive Oxygen Species in the Pathogenesis of Chronic Kidney Disease: Lessons Derived from Diabetic Nephropathy
    Naoki Kashihara, Minoru Satoh, Yashpal S. Kanwar · 2014 · Springer eBooks
  53. World Kidney Day 2011: Protect your kidneys, save your heart
    William G. Couser, Miguel Carlos RIELLA · 2011 · Pediatric Nephrology
  54. Inherited or Acquired in Hipertension and Cronic Kidney Disease in Diabetes Mellitus Patients?
    Marilena Stoian, Ana Maria Dumitrache, Fivi Cîrciu, Victor Stoica, Gabriela Radulian · 2021 · Internal Medicine
  55. Gliflozins slow down the progression of diabetic kidney disease
    Vladimı́r Tesař, Jan Vachek · 2017 · Vnitřní lékařství
  56. calculated-10-years-risk-of-chd-primary-preventive-measures-in-medical-ward-ppukm-university-kebangsaan-malaysia-medical-centre
    Rosnani Hashim, Semira Abdi Beshir · 2011 · Malaysian Journal of Pharmacy
  57. Xiao Zheng San Jie Granules in the Treatment of Qi Deficiency and Blood Stasis Syndrome in Patients With Diabetic Kidney Disease Stage IV: Protocol for a Randomised, Double-blind, Placebo-controlled, Multi-centre Trial
    Sinan Ai, Yizhen Han, Yabin Gao, Yaoxian Wang, Jingwei Zhou, Weijing Liu, Xueting Han, Zhenjie Chen, Qingqing Liu, Weihong Chen et al. · 2021 · Research Square
  58. Composite Endpoints in Cardio-Renal Clinical Outcome Trials
    Hung Hung, John Lawrence · 2021 · Statistics in Biopharmaceutical Research
  59. Lettre à l’éditeur, en réponse à l’article « Les inhibiteurs du SGLT2 : une nouvelle ère pour nos patients »
    Thierry P. Hannedouche, Gerald Roul · 2021 · Néphrologie & Thérapeutique
  60. Practical Pearls in the Treatment of Hypertension in Blacks
    Elijah Saunders, Jude Ediae · 2014 · Springer eBooks
  61. Pattern Based Classification of Chronic Kidney Disease Patients
    Megan Moreno, Melissa Cole · 2021
  62. Therapeutic Inertia in the Management of Proteinuria Among Type 2 Diabetes Patients in Hong Kong Primary Care Setting: Prevalence and Associated Risk Factors
    FU Leung Chan, Xiao Rui Catherine Chen, Yim Chu Li · 2020 · Research Square
  63. Clinical Trials on Diabetic Kidney Disease: What Have We Learned from Landmark Trials?
    Vecihi Batuman · 2019
  64. Rigenerazione e Proteinuria, Quando L'albumina Fa La Differenza
    Duccio Lombardi · 2014 · Giornale di Clinica Nefrologica e Dialisi
  65. Disparities in the Treatment of CKD and Efforts to Slow Progression
    Moro O. Salifu, Susanne B. Nicholas · 2019
  66. Diabetische Nephropathie
    Michael Resl, Martin Clodi · 2011 · Wiener klinische Wochenschrift Education
  67. Genetic Risk Scores and Blood Pressure — The Heart is What Matters
    Mirna Boumitri, Nayanjot Kaur Rai, Paul E. Drawz · 2021 · Kidney360
  68. Bloqueio da ativação do receptor do EGF em ratos deficientes em vitamina D submetidos à nefrectomia 5/6: efeitos do tratamento duplo losartana/erlotinib na formação de fibrose renal
    Janaína Garcia Gonçalves · 2021
  69. Educateur technique spécialisé
    Fondation Massé Trévidy · 2021
  70. Efficacy and Safety of Candesartan 16 mg versus 64 mg Candesartan in Renal Disease Patients with Proteinuria: A Systematic Review and Meta-analysis
    Andry Gonius, Arnaz Adisaputra, Farahdina Farahdina · 2021 · Open Access Macedonian Journal of Medical Sciences
  71. Erkrankungen von Niere und Urogenitaltrakt
    Walter Hermann Hörl, Wilfred Druml, Alexander R. Rosenkranz et al. · 2003 · Springer eBooks
  72. El factor natriurético atrial en la cirrosis hepática
    L.L.Titó Espinagosa · 1991 · Dialnet (Universidad de la Rioja)
  73. Japan-Indonesia Collaborative Study of Imidapril on Antiproteinuric Effect in Hypertensive Patients with Chronic Kidney Disease (CKD)
    Toshinao Tsuge, Wiguno Prodjosudjadi, Mohammad Yogiantoro, Atsushi Kurusu, Isao Ohsawa, NORTYOSHI KOBAYASHI, YOSHIO SHIMIZU, Ginova Nainggolan, AIDA LIDYA, Chandra Irwanadi Mohani et al. · 2010 · Juntendō Igaku/Juntendo igaku
  74. Cardiovascular Disease: Coronary Artery Disease and Coronary Artery Calcification
    Srinivasan Beddhu · 2010 · Springer eBooks
  75. HEART's Selection INNOVATION試験-INcipieNt to OVert:Angiotensin II receptor blocker,Telmisartan, Investigation On type 2 diabetic Nephropathy
    横山 健 · 2008 · 心臓
  76. Puromycin aminonucleoside腎症の間質障害に対するMycophenolate mofetilならびにOlmesartanの抑制効果に関する研究
    佐藤 かすみ, 幸寛 和田, 利男 諸星 · 2005 · 昭和医学会雑誌
  77. アンジオテンシンII 1型受容体拮抗薬からロサルタン・ヒドロクロロチアジド合剤への変更が血圧, 腎臓, 代謝に与える影響 血圧コントロールが不十分な2型糖尿病患者における検討 (KOLABO study)
    大塚章人, 武田 浩一郎, 久保聡子 · 2011 · 糖尿病
  78. Characterization of Patients With Type 2 Diabetes and Chronic Kidney Disease in a Large Integrated Health System
    Kevin M. Pantalone, Xinge Ji, Sheldon Xiaodong Kong, Jay Elliott, Alex Milinovich, Anita D. Misra‐Hebert, Ryan Farej, Rakesh Singh, Janine M. Bauman, Robert S. Zimmerman et al. · 2021 · Research Square
  79. The effect of modern hypoglycemic therapy on the course of chronic kidney disease in patients with type 2 diabetes mellitus
    V.I. Katerenchuk · 2021 · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
  80. Understanding the biological role of the carnosine-carnosinase system in diabetes and beyond
    Maria Rodriguez Niño · 2021
  81. ACE-Hemmer und Angiotensinrezeptorantagonisten
    Manfred Anlauf · 2004 · Springer eBooks
  82. Pathogenesis: Hemodynamic Alterations
    María José Soler, Conxita Jacobs-Cachá, Manga Motrapu, Hans‐Joachim Anders · 2022 · Springer eBooks
  83. Atypical Presentations
    Louis J. Imbriano, Nobuyuki Miyawaki, Joseph Mattana, Shayan Shirazian, John K. Maesaka · 2022 · Springer eBooks
  84. Hypertonie
    Gerit-Holger Schernthaner · 2005 · Steinkopff eBooks
  85. Kardiovaskuläre Pharmakologie
    Florian Custodis, Michael Böhm · 2006 · Steinkopff eBooks
  86. Antihypertensive Therapies
    W.J. Elliott · 2022 · Springer eBooks
  87. Historical Background of Diabetic Kidney Disease
    Vivian Andrew Fonseca, Arezu Bhatnagar, Govind Datta Chamarthi · 2022 · Springer eBooks
  88. Diuretics
    Domenic A. Sica · 2002 · Side effects of drugs annual
  89. Diabetic Nephropathy
    Alessia Fornoni, Carlos León, Leopoldo R. Raij · 2007 · Springer eBooks
  90. Diuretics
    2006 · Elsevier eBooks
  91. Evaluation of Diabetic Nephropathy and Associated Risk Factors in Type I and Type II Diabetic Patients at Badin, Sindh
    Ghulam Sadiq, Rizwan Ali, Abdul Samad · 2022 · Pakistan Journal of Medical and Health Sciences
  92. Glomeruläre Erkrankungen
    Alexander R. Rosenkranz, Gert J. Mayer · 2006 · Springer eBooks
  93. Glomeruläre Erkrankungen
    Alexander R. Rosenkranz, Gert J. Mayer · 2007 · Springer eBooks
  94. Faculty Opinions recommendation of Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.
    Enyu Imai · 2011 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  95. Diabetic Nephropathy
    2006 · Wiley Handbook of Current and Emerging Drug Therapies
  96. Arterial Hypertension in Diabetes: Etiology and Treatment
    George L. Bakris, Nauman Tarif, Henry Richard Black · 2003
  97. References
    2004 · American Journal of Kidney Diseases
  98. Management of the Hypertensive Child
    Demetrius Ellis, Yosuke Miyashita · 2014 · Springer eBooks
  99. Type 1 Diabetes Mellitus
    David W. Gardner, Khurshid Khan, Gurushankar Govindarajan, John C. Palmer, James R. Sowers · 2006 · CRC Press eBooks
  100. Chapter 1: Introduction
    2007 · European Journal of Cardiovascular Prevention & Rehabilitation